Increased proportion of CD226  + CD14 + monocytes correlates with clinical features and laboratory parameters in patients with primary Sjögren's syndrome

ConclusionOur study suggested that an increased CD226 proportion on CD14  + monocytes was associated with the clinical manifestations, disease activity, and prognosis of pSS patients. CD226+ CD14 + monocytes may present a potential target and a biomarker for the prognosis and therapy of pSS patients.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Tags: ORIGINAL ARTICLE Source Type: research